News
News and updates in the research and development of digital biomarkers and wearable sensor technologies.
Events
News
January 24, 2023
$2.5M NIH Award to Develop a Multi-Modal Remote Monitoring Solution for FTLD Syndromes
BioSensics is pleased to announce a $2.5M/2-year award from the U.S. National Institute of Health (NIH) to develop a robust multi-modal solution for remote monitoring of motor, speech, and cognitive function in Frontotemporal lobar degeneration (FTLD) syndromes.
Read more
November 30, 2022
NIH Selects BioSensics to Develop Remote Measurement Technologies for Rare Diseases
BioSensics has been selected by the U.S. National Institute of Health to develop remote measurement technologies for use in clinical trials in individuals with rare diseases.
Read more
November 14, 2022
$2.5M NIH Award to Develop a Multi-Modal Monitoring Solution for Myasthenia Gravis
BioSensics has been awarded a $2.5M/3-year NIH award to develop a multi-modal monitoring solution of myasthenia gravis.
Read more
November 2, 2022
Upper Extremity Motor Assessment in Ataxia | ICAR 2022
Upper Extremity Motor Assessment in Ataxia using BioSensics Wearable Sensors
Read more
October 17, 2022
PAMSys as Secondary Endpoint for MSA | Digital Biomarkers Summit
PAMSys is used as a secondary endpoint in a Phase 2 trial in Multiple System Atrophy.
Read more